These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 16859505

  • 1. Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding.
    Klitgaard T, Tabanera y Palacios R, Boffard KD, Iau PT, Warren B, Rizoli S, Rossaint R, Kluger Y, Riou B, NovoSeven Trauma Study Group.
    Crit Care; 2006; 10(4):R104. PubMed ID: 16859505
    [Abstract] [Full Text] [Related]

  • 2. The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage.
    Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B, NovoSeven Trauma Study Group.
    Transfusion; 2009 Dec; 49 Suppl 5():240S-7S. PubMed ID: 19954486
    [Abstract] [Full Text] [Related]

  • 3. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
    Rizoli SB, Boffard KD, Riou B, Warren B, Iau P, Kluger Y, Rossaint R, Tillinger M, NovoSeven Trauma Study Group.
    Crit Care; 2006 Dec; 10(6):R178. PubMed ID: 17184516
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa.
    Lindley CM, Sawyer WT, Macik BG, Lusher J, Harrison JF, Baird-Cox K, Birch K, Glazer S, Roberts HR.
    Clin Pharmacol Ther; 1994 Jun; 55(6):638-48. PubMed ID: 8004880
    [Abstract] [Full Text] [Related]

  • 5. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.
    Geeraedts LM, Kamphuisen PW, Kaasjager HA, Verwiel JM, van Vugt AB, Frölke JP.
    Injury; 2005 Apr; 36(4):495-500. PubMed ID: 15755430
    [Abstract] [Full Text] [Related]

  • 6. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
    Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E.
    Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
    [Abstract] [Full Text] [Related]

  • 7. Recombinant activated coagulation factor VII and bleeding trauma patients.
    Rizoli SB, Nascimento B, Osman F, Netto FS, Kiss A, Callum J, Brenneman FD, Tremblay L, Tien HC.
    J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.
    Berrettini M, Mariani G, Schiavoni M, Rocino A, Di Paolantonio T, Longo G, Morfini M.
    Haematologica; 2001 Jun; 86(6):640-5. PubMed ID: 11418374
    [Abstract] [Full Text] [Related]

  • 12. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
    Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B, CONTROL Study Group.
    J Trauma; 2010 Sep; 69(3):489-500. PubMed ID: 20838118
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol.
    Girard P, Nony P, Erhardtsen E, Delair S, Ffrench P, Dechavanne M, Boissel JP.
    Thromb Haemost; 1998 Jul; 80(1):109-13. PubMed ID: 9684795
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
    Kluger Y, Riou B, Rossaint R, Rizoli SB, Boffard KD, Choong PI, Warren B, Tillinger M.
    Crit Care; 2007 Jul; 11(4):R85. PubMed ID: 17686152
    [Abstract] [Full Text] [Related]

  • 19. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.
    Mohr AM, Holcomb JB, Dutton RP, Duranteau J.
    Crit Care; 2005 Jul; 9 Suppl 5(Suppl 5):S37-42. PubMed ID: 16221318
    [Abstract] [Full Text] [Related]

  • 20. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B, Wiis J.
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.